AzTrials
AzTrials

Severe SepsisEIDECSNCT01247792

End-of-life Decision-making in Patients With Sepsis-related Organ Failure

A study testing SOPs for decision-making and communication in people with Severe Sepsis, run by Center for Sepsis Control and Care, Germany at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The care of patients with sepsis-related organ failure on the intensive care unit (ICU) often includes end-of-life decision (EOL-D) and communication of such decisions to relatives. This increases the psychological burden for caregiver and relatives. Read more about this study

Who is it for?
Any age
Conditions the study is for
Severe Sepsis
What is being tested?
SOPs for decision-making and communication
Could I receive a placebo?
No, everyone receives an active treatment
How many people
174 participants
Where
1 siteGermany
Study dates
Aug 2010to 30 Sep 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • all physicians and nursing staff who treat patients with sepsis-related organ failure on participating ICUs who consent to participate

Who cannot join

  • Decline to participate
  • Relatives:
  • Relatives of patients with sepsis-related organ failure and EOL-D who consent to participate
  • Decline to participate

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Jena University Hospital

    Jena, Thuringia, 07747

Other trials in Germany

About this study

Official title: A Time-series Intervention Analysis of End-of-life Decision-making in Patients With Sepsis-related Organ Failure

The care of patients with sepsis-related organ failure on the intensive care unit (ICU) often includes end-of-life decision (EOL-D) and communication of such decisions to relatives. This increases the psychological burden for caregiver and relatives.

The investigators intend to assess the prevalence and impact of EOL-D on ICU care-givers and relatives ("before") and to use this data to develop and implement standard operating procedures (SOPs) for improved decision-making and communication of these decisions ("after").

The hypothesis is that an improved communication strategy will reduce symptoms of burnout in caregivers and symptoms of anxiety and depression in relatives.

Read the detailed description

BACKGROUND About half of patients with sepsis related organ failure die on the ICU, frequently after end-of-life decisions (EOL-D), i.e. the decision to withdraw or withhold life-supporting therapies or forgo cardiopulmonary resuscitation. Lack of SOPs about how to communicate and share EOL-decisionmaking among staff and to communicate EOL-D to relatives may increase burnout and anxiety in staff as well as relatives. Also, there is uncertainty about the role of patients' advance directives in EOL-Decision-making.

HYPOTHESES 1. SOPs for interdisciplinary EOL-decisions will alleviate staff burnout; 2. A structured strategy to communicate EOL-decisions to relatives will lead to reduced anxiety and depression in relatives 3 months after the event.

AIMS 1. to develop SOPs for EOL-decision-making which improve timeliness of EOL-D and involvement of interdisciplinary care-givers. 2. to develop a strategy how to communicate these EOL-D to relatives including a structured procedure for participants, set-up, times and content. These aims may be adapted according to the findings of the observation period.

CONDUCT The study is designed as an interrupted time series analysis ("before/after study") located on the mixed, neurological and medical ICUs of the Jena University Hospital. It is composed of 3 observation periods separated by phases of data analysis and implementation of changes in behavioral practice. After the first phase of observation and data analysis, SOPs including an improved communication strategy with relatives will be developed on the basis of the collected data. SOPs will be developed and implemented on participating ICUs. In the following second observation period data will be collected to assess changed procedures and primary endpoints. A third round of data analysis, interpretation and observation will enable to further adapt SOPs and achieve sustainability ("post-implementation phase").

ESTIMATED ENROLLMENT Enrollment of 180 staff members (physicians and nursing staff) and 90 relatives during each study phase

Conditions
Severe Sepsis
Being tested
SOPs for decision-making and communication
Keywords
sepsis, organ failure, end-of-life decisions, patient-centered communication
Medical subject headings
Sepsis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SOPs for decision-making and communicationBehavioural

    Development and implementation of SOPs for timely and interdisciplinary EOL-decisionmaking and a communication strategy with relatives which addresses participants, set-up, time-points, and content

Study groups in NCT01247792
Study groupRoleWhat they receive
"Before"No interventionNo Intervention Observation of current practice
"After"OtherSOPs for decision-making and communication Assessment of practice after implementation of SOPs
Receives: Behavioral: SOPs for decision-making and communication

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Symptoms of burnout by MBI score in ICU caregivers

    Measured: once during observation period (1 year)

  2. Symptoms of post-traumatic stress disorder by IES and HADS scores in relatives at 90 days

    Measured: once during observation period (1 year)

Secondary outcomes (7)
  1. Psychological symptoms by IES, HADS or MBI subscales in caregivers or relatives, respectively

    Measured: once during the observation period (1 year)

  2. Characteristics of patients with and without end-of-life decisions (EOL-D) including time periods (time until EOL-D, time between EOL-D until death or discharge) and 28-day and 90-day mortality rates

    Measured: until death or discharge from the ICU

  3. Prevalence and characteristics of EOL-D

    Measured: until death or discharge from the ICU

  4. Prevalence and characteristics of patients' advance directives

    Measured: until death or discharge from the ICU

  5. characteristics of EOL-D communication with relatives

    Measured: ICU stay

  6. Prevalence of request for "Ethik Konsil" (counseling by an external ethical review board)

    Measured: until death or discharge from the ICU

  7. direct costs of treatment of survivors and non-survivors

    Measured: until death or discharge from the ICU

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Nov 2010 (estimated)
  2. Study startAug 2010
  3. Primary completion30 Sep 2014
  4. Study completion30 Sep 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
174 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01247792
Sponsor's protocol ID
EIDECS
Acronym
EIDECS
Status last verified
Aug 2017
First submitted
11 Nov 2010
Last updated
9 Aug 2017
Results posted
No
Data monitoring committee
No

Publications

  • Lautrette A, Darmon M, Megarbane B, Joly LM, Chevret S, Adrie C, Barnoud D, Bleichner G, Bruel C, Choukroun G, Curtis JR, Fieux F, Galliot R, Garrouste-Orgeas M, Georges H, Goldgran-Toledano D, Jourdain M, Loubert G, Reignier J, Saidi F, Souweine B, Vincent F, Barnes NK, Pochard F, Schlemmer B, Azoulay E. A communication strategy and brochure for relatives of patients dying in the ICU. N Engl J Med. 2007 Feb 1;356(5):469-78. doi: 10.1056/NEJMoa063446.

    PubMed 17267907
  • Embriaco N, Papazian L, Kentish-Barnes N, Pochard F, Azoulay E. Burnout syndrome among critical care healthcare workers. Curr Opin Crit Care. 2007 Oct;13(5):482-8. doi: 10.1097/MCC.0b013e3282efd28a.

    PubMed 17762223
  • Schwarzkopf D, Westermann I, Skupin H, Riedemann NC, Reinhart K, Pfeifer R, Fritzenwanger M, Gunther A, Witte OW, Hartog CS. A novel questionnaire to measure staff perception of end-of-life decision making in the intensive care unit--development and psychometric testing. J Crit Care. 2015 Feb;30(1):187-95. doi: 10.1016/j.jcrc.2014.09.015. Epub 2014 Sep 20.

    PubMed 25311265
  • Hartog CS, Schwarzkopf D, Riedemann NC, Pfeifer R, Guenther A, Egerland K, Sprung CL, Hoyer H, Gensichen J, Reinhart K. End-of-life care in the intensive care unit: a patient-based questionnaire of intensive care unit staff perception and relatives' psychological response. Palliat Med. 2015 Apr;29(4):336-45. doi: 10.1177/0269216314560007. Epub 2015 Jan 29.

    PubMed 25634628

Questions about this trial

What is this clinical trial studying?

A study testing SOPs for decision-making and communication in people with Severe Sepsis, run by Center for Sepsis Control and Care, Germany at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Symptoms of burnout by MBI score in ICU caregivers (time frame: once during observation period (1 year)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01247792, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Aug 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in